Authors:
Burgess, K
Han, I
Zhang, A
Zheng, WH
Shanmugam, K
Featherstone, MS
Saragovi, HU
Citation: K. Burgess et al., DiSSiMiL: Diverse Small Size Mini-Libraries applied to simple and rapid epitope mapping of a monoclonal antibody, J PEPT RES, 57(1), 2001, pp. 68-76
Authors:
Zaccaro, MC
Ivanisevic, L
Perez, P
Meakin, SO
Saragovi, HU
Citation: Mc. Zaccaro et al., p75 co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains, J BIOL CHEM, 276(33), 2001, pp. 31023-31029
Citation: V. Guillemard et Hu. Saragovi, Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity, CANCER RES, 61(2), 2001, pp. 694-699
Citation: Hu. Saragovi et K. Gehring, Development of pharmacological agents for targeting neurotrophins and their receptors, TRENDS PHAR, 21(3), 2000, pp. 93-98
Authors:
la Sala, A
Corinti, S
Federici, M
Saragovi, HU
Girolomoni, G
Citation: A. La Sala et al., Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis, J LEUK BIOL, 68(1), 2000, pp. 104-110
Authors:
Maliartchouk, S
Feng, YB
Ivanisevic, L
Debeir, T
Cuello, AC
Burgess, K
Saragovi, HU
Citation: S. Maliartchouk et al., A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors, MOLEC PHARM, 57(2), 2000, pp. 385-391
Authors:
Sendera, TJ
Ma, SY
Jaffar, S
Kozlowski, PB
Kordower, JH
Mawal, Y
Saragovi, HU
Mufson, EJ
Citation: Tj. Sendera et al., Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome, J NEUROCHEM, 74(3), 2000, pp. 1185-1196
Authors:
Beglova, N
Maliartchouk, S
Ekiel, I
Zaccaro, MC
Saragovi, HU
Gehring, K
Citation: N. Beglova et al., Design and solution structure of functional peptide mimetics of nerve growth factor, J MED CHEM, 43(19), 2000, pp. 3530-3540
Authors:
Maliartchouk, S
Debeir, T
Beglova, N
Cuello, AC
Gehring, K
Saragovi, HU
Citation: S. Maliartchouk et al., Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action, J BIOL CHEM, 275(14), 2000, pp. 9946-9956
Citation: Hu. Saragovi et K. Burgess, Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents, EXPERT OP T, 9(6), 1999, pp. 737-751
Authors:
Shanmugam, K
Green, NC
Rambaldi, I
Saragovi, HU
Featherstone, MS
Citation: K. Shanmugam et al., PBX and MEIS as non-DNA-binding partners in trimeric complexes with HOX proteins, MOL CELL B, 19(11), 1999, pp. 7577-7588
Citation: T. Debeir et al., A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat, P NAS US, 96(7), 1999, pp. 4067-4072
Authors:
Saragovi, HU
Zheng, WH
Maliartchouk, S
DiGugliemo, GM
Mawal, YR
Kamen, A
Woo, SB
Cuello, AC
Debeir, T
Neet, KE
Citation: Hu. Saragovi et al., A TrkA-selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals, J BIOL CHEM, 273(52), 1998, pp. 34933-34940